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common, with a crude incidence in adults of less than 
0.5 % in various situations [1–5]. With improved patient 
survival [6–8], RIS is likely to be encountered more fre-
quently. It is now generally believed that complete surgi-
cal resection of RIS provides the only chance of a cure [3, 
4]. Unfortunately, the reported prognosis is poor owing 
to advanced RIS at diagnosis [3, 4, 9]. RIS has become a 
critical problem that can limit long-term survival and hin-
der quality of life. To detect an RIS at an earlier stage, the 
radiologist should be aware of the common radiological 
appearances, which can be scrutinized on follow-up scans.
The purpose of this study was to document the clinical 
findings and the radiological features on computed tomog-
raphy (CT) and magnetic resonance imaging (MRI) of RIS 
in the head and neck following RT for NPC.
Materials and methods
Patients
The institutional ethics review board approved this retro-
spective study and waived the need for informed consent. 
Patients with RIS in the head and neck following RT for 
NPC identified from a review of the histological and radio-
logical results from December 1998 to September 2012 met 
the inclusion criteria. The clinical records were reviewed to 
determine histology, latency period, clinical presentation 
and treatment. The diagnostic criteria of patients with RIS 
was based on the criteria published by Cahan et al. [10]: 
a prior history of RT; the occurrence of a sarcoma within 
the previously irradiated field; a latency between irradia-
tion and the second primary sarcoma of at least 3 years; 
histologically proven sarcoma arising within the irradiated 
field. One of the co-authors engaged in the pathological 
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Abbreviation
RT  Radiotherapy
NPC  Nasopharyngeal carcinoma
SCC  Squamous cell carcinoma
RIS  Radiation-induced sarcomas
CT  Computed tomography
MRI  Magnetic resonance imaging
Introduction
Radiotherapy (RT) is the curative treatment modality for 
nasopharyngeal carcinoma (NPC), which is a common 
tumor in the southern Chinese population. However, ioniz-
ing radiation is itself a known carcinogen. There is a large 
population at risk of developing sarcomas in the irradi-
ated fields. Compared with post-radiation squamous cell 
carcinoma (SCC) [1], radiation-induced sarcomas (RIS) 
of the head and neck following RT for NPC are even less 
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diagnosis. Patients of RIS without CT or MRI materials 
in our institution or without clinical data were excluded 
(Fig. 1).
Radiation techniques
The radiation techniques that were used in this study had 
been described in detail by other colleagues in our hospital 
[11, 12]. The radiation fields for the nasopharynx normally 
included two opposite preauricular fields. For patients with 
nasal cavity or poststyloid area invasion, an anterior or 
postauricular supplementary field was added. At the cervi-
cal region, the anterior and posterior split fields were used 
in the first period and perpendicular small opposing fields 
in the second. In this study, the primary nasopharyngeal 
tumors were treated with a dose of 40–90 Gy with the aver-
age dose of 68.7 Gy, and the neck received 37–70 Gy with 
the average dose of 57.7 Gy, depending on the lymph nodes 
involvement.
CT and MRI examinations
A 16-slice spiral CT (Brilliance TM 16, Philips Medi-
cal Systems, the Netherlands) or a dual-slice CT (Twin 
FLASH, Philips Medical Systems, the Netherlands) was 
used for multiphasic CT scans (i.e., nonenhanced phase, 
arterial and venous phases). Other parameters were as fol-
lows: section thickness, 5 or 10 mm; gap, 5 or 10 mm; tube 
current, 250 mA; and tubular voltage, 125 kV. The contrast-
enhanced CT scanning was performed after an intravenous 
injection of iopromide at a dosage of 1.5 ml/kg of body 
weight (Ultravist 300, Schering, Germany).
The MRI was performed using a 1.5 T superconductive 
unit (Signa Horizon LX Highspeed, General Electric Med-
ical Systems, USA) with a head coil and a neck coil or a 
combined head and neck coil. The sequences included spin 
echo sagittal, coronal and transverse T1-weighted images 
(TR/TE = 2000 ms/120 ms) and fast spin echo sagittal 
T2-weighted images (TR/TE = 450 ms/15 ms). Contrast-
enhanced sagittal, coronal and transverse T1-weighted 
images were obtained after the intravenous injection of 
gadopentetate dimeglumine (Magnevist, Schering, Berlin, 
Germany) at a dosage of 0.2 mmol/kg of body weight. The 
fat-suppression technique was used for the gadolinium-
enhanced T1-weighted coronal images in 15 patients.
Among the 69 patients, 41 cases underwent CT exami-
nation only, 21 cases MRI only, and the remaining 7 cases 
both CT and MRI scans. In all patients, contrast-enhanced 
examinations were performed.
Images evaluation
CT and MRI images were reviewed by the two experienced 
head and neck authors (one with more than 20 years and 
another with 4 years of experience, respectively) and deci-
sions were reached by consensus.
Images were assessed with an emphasis on the fol-
lowing aspects: (a) the site or origin of lesions; (b) lesion 
size (measured at its greatest diameter); (c) density/signal 
intensity of lesions and pattern, degree of enhancement; (d) 
extent of lesions including bone destruction.
Fig. 1  Flowchart showing patient recruitment
Table 1  Patient characteristics at diagnosis of nasopharyngeal carci-
noma (n = 69)
WHO World Health Organization, IMRT intensity-modulated radio-
therapy
a 13 cases and b12 cases without records, respectively
Characteristic No. of patients %
Sex
 Men 46 66.67
 Women 23 33.33
Age (year)
 ≤30 15 21.74
 >30 54 78.26
TNM stagea
 I/II 24 34.78
 III/IV 32 46.38
Histological typeb
 WHO type I 0
 WHO type II and III 57 82.61
Radiation techniqueb
 Conventional radiotherapy 57 82.61
 IMRT 0
Radiation dose (Gy)b
 ≥55 56 81.16
 <55 1 1.45




A total of 69 patients (from 27714 patients) with histo-
logical evidence of RIS were enrolled, including 46 men 
and 23 women with a ratio of 2:1. The median age at the 
diagnosis of RIS was 48 years (year) (range 21–71 years). 
Patients’ characteristics at diagnosis of NPC are shown in 
Table 1.
Clinical presentation and latency
The symptoms were related to the sites of RIS. Among 
them, 42 patients presented with well-marked mass in the 
maxillofacial region and neck accompanied by pain of cer-
tain degrees, 7 patients with serious loss of vision and 20 
patients with nasal obstruction and/or bleeding similar to 
the symptoms of primary NPC.
The average latency period from the end of radiation 
therapy to the diagnosis of RIS was 10.8 years (range 
3–37 years). Most of RIS (44.9 %) occurred at 5–10 years 
after RT, and up to 87.0 % of RIS developed within 
15 years after RT (Table 2). The median latency of RIS 
originating in the maxillofacial region and in the neck was 
similar, at 10.8 years with a range of 3–37 and 5–19 years, 
respectively.
Imaging features
The main characteristic of the 69 RIS on CT and MRI was 
soft tissue mass formation. All cases showed heterogeneous 
density/signal intensity before and after intravenous admin-
istration of contrast medium, and 43 of them had marked 
enhancement compared with adjacent muscles. Most of the 
solid areas of RIS showed high T2 signal intensity on MRI. 
82.6 % of the lesions (n = 57) were ill defined, widely 
extending to adjacent spaces and had bone destruction or 
blood vessel infiltration. The lesion sizes ranged from 0.7 
to 8.2 cm with the average diameter of 4.3 cm, and lesions 
≥3 cm accounted for 63.8 %, lesions ≥5 cm accounted for 
30.4 %.
RIS in the current study showed variations in location 
and histological subtype. The locations and histologic sub-
types of RIS are presented in Table 3 (Figs. 2, 3, 4, 5, 6). 
All the sarcomas in this study occurred at sites, while in 
the irradiated field, away from the margins of the origi-
nal tumor of NPC and the metastatic lymph nodes. The 
most common origin sites of RIS were the maxillary sinus 
(n = 20), neck (n = 14) and mandibular ramus (n = 11). 
The largest histological group was osteosarcoma (n = 24), 
followed by fibrosarcoma (n = 22) and undifferentiated 
pleomorphic sarcoma (n = 8). The clinically determined 
site of RIS was superficial (cutaneous or subcutaneous) 
in 39 patients and deep in 30 patients. RIS originated in 
bone in 48 patients with the common histologic types of 
osteosarcoma (n = 24) and fibrosarcoma (n = 10) and 
in soft tissue in 21 patients with the common subtype of 
Table 2  The latency period from the end of radiation therapy to the 
diagnosis of radiation-induced sarcomas (n = 69)
Characteristic No. of patients %
Latency (year)
 3–5 12 17.39
 5–10 31 44.93
 10–15 17 24.64
 15–20 4 5.79
 >20 5 7.25
Table 3  Locations, histologic types and imaging findings of radiation-induced sarcomas (n = 69)
UPS undifferentiated pleomorphic sarcoma, LGMS low-grade myofibroblastic sarcoma
a The median age at the diagnosis of radiation-induced sarcomas
b The most common site
c The results of aspiration biopsy, the only diagnosis of sarcoma, unable to perform further classification
Histology No. % Median agea (year) Latency (year) Siteb
Osteosarcoma 24 34.78 49 10.8 Maxillary sinus and mandibular ramus
Fibrosarcoma 22 31.88 48 11.8 Neck, maxillary sinus and mandibular ramus
UPS 8 11.59 42 6.1 Maxillary sinus and Nasal cavity
LGMS 2 2.9 52 9.5 Maxillary sinus and Lower neck
Carcinosarcoma 1 1.45 50 8 Upper alveolar bone
Chondrosarcoma 1 1.45 41 6 Sphenoid sinus
Neurofibrosarcoma 1 1.45 56 11 Lower neck
Hemangiosarcoma 1 1.45 42 5 Wing jaw
Undifferentiated sarcomac 9 13.04
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fibrosarcoma (n = 12), respectively. Among the 24 osteo-
sarcomas, a large amount of tumor bone formation was 
seen in 10 cases. A subgroup comparison of radiological 
findings between osteosarcoma and fibrosarcoma is sum-
marized in Table 4.      
Treatment and clinical follow‑up
Treatment and outcomes of the RIS are shown in Table 5. 
There were 60 patients receiving varied managements in 
our hospital. Apart from 8 patients having no follow-up 
data, a total of 46 patients had recurrent or uncontrolled 
lesions exactly at the original site of RIS until the end of 
the study/follow-up, accounting for 88.5 %. 47 patients 
received surgery, among them 5 patients received adjuvant 
chemotherapy or RT and 36 patients had recurrent lesions. 
The median latency from the surgery to the diagnosis of 
recurrence was 5.5 months (average 9.1 months, range 
0.5–54 months). All of the other 10 patients who received 
chemotherapy only (n = 8), RT only (n = 1) or chemora-
diation (n = 1) had uncontrolled lesions.
Discussion
Patients with NPC treated with radiotherapy are at risk of 
developing radiation-induced sarcomas in the irradiated 
fields. RIS in NPC are even rare, with a crude incidence of 
0.25 % in this study, which is generally consistent with pre-
vious findings. In this study, we retrospectively reviewed 
the clinical and CT/MRI features of RIS, and the results 
showed that RIS was very aggressive and had poor progno-
sis for most cases. Here, one thing to say is that among the 
69 patients enrolled in this study, 54 had been documented 
focusing on the locations and histological subtypes of RIS 
in one of our previous studies [2].
We acknowledge that not all sarcomas that arise after 
RT are induced by radiation, so do the cases in our study; 
but it is impossible to differentiate RIS from primary sar-
comas. We defined an RIS with a latency of at least 3 years 
after RT mentioned above. RIS in this study arose as a late 
complication of radiotherapy at an average latency period 
of 10.8 years, which was in agreement with the previ-
ously reported latency periods ranging from 8.8 years to 
Fig. 2  Radiation-induced osteosarcoma 17 years after radiotherapy 
of a 58-year-old man. a Axial contrast-enhanced CT image showed 
a large heterogeneous tumor in the right maxillary sinus invading the 
nasal cavity (arrows); b axial T2-weighted image showed heterogene-
ously high T2 signal intensity of the tumor; c coronal T1-weighted 
contrast-enhanced image showed the mildly enhanced tumor with 
wide invasion into the right maxillary region (arrows)
◂
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12.4 years [1–3, 13]. As many as 87.0 % of RIS developed 
within 15 years after RT, and the longest latency was up 
to 37 years after RT, which indicates that a long period of 
attention on RIS for patients treated with RT for NPC is 
necessary. But it should be noted that intensive follow-up 
is not necessary; patients just need to comply with the pre-
scribed periodic follow-ups for NPC by radiation oncolo-
gist; and we radiologists should carefully scrutinize the 
scans, especially the irradiated field, to avoid missing any 
potential RIS lesions.
RIS had a predilection for arising in the high-radiation-
dose region, and it is known that a total dose of 55 Gy or 
above increases their risk [1, 14]; our results supported the 
published findings. Patients undergoing a full course of 
RT for NPC received an average dose of about 68.7 Gy to 
the nasopharynx in this study, thus putting the surrounding 
bones and soft tissues at risk of RIS. The dose of radiation 
increases further in cases where there is local tumor inva-
sion into the parapharyngeal region [15]. In this series, the 
most common origin site of RIS was the maxillary region, 
which encompasses at least the posterior half of the max-
illary sinus and adjacent nasal cavity receiving almost the 
full radiation dose; and followed by the neck which received 
an average dose of about 57.7 Gy with lymph node0 
involvement. We documented a similar observation that had 
been made previously [1–3, 9]. This highlighted the impor-
tance of inspecting the previously irradiated fields, espe-
cially the high-radiation-dose regions, on CT and (or) MRI 
follow-up scans to improve early detection of RIS.
Despite the small number of cases in this study, a wide 
variety of sites and subtypes of RIS were seen. Some of 
Fig. 3  Radiation-induced osteosarcoma 10 years after radiotherapy 
of a 53-year-old man. Axial contrast-enhanced CT image showed a 
large heterogeneous tumor, with a large amount of tumor bone for-
mation, arising from the right mandibular ramus destroying the right 
masseter muscle and medial pterygoid muscle (arrows)
Fig. 4  Radiation-induced fibrosarcoma 5 years after radiotherapy of 
a 35-year-old woman. Axial T1-weighted contrast-enhanced image 
(a) and coronal fat-suppressed T1-weighted contrast-enhanced image 
(b) showed a large heterogeneously marked enhanced tumor of the 
right mandibular ramus with bone destruction and wide invasion into 
the muscles (arrows)
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the patients from January 2000 to December 2011 had 
been reported by Cai et al. focusing on the imaging find-
ings of RIS [2]. Patients in this study were collected from 
December 1998 to September 2012; additionally, we sum-
marized the treatment and outcomes of RIS in our institu-
tion, some of the patients included in the previous study had 
been excluded in this study owing to missing clinical data or 
treated in other institutions. As a result, the most common 
locations and frequency number of histologic types of RIS 
showed some difference in this study. In addition to some 
osteosarcomas with tumor bone formation, the other sar-
comas had almost similar appearances on CT or MRI. The 
hallmark of RIS was heterogeneous soft tissue mass with 
marked contrast enhancement. Most sarcomas in the series 
were large with extensive local invasion at the time of CT or 
MRI, 30.4 % of which were ≥5 cm. This is partly because 
they are very aggressive tumors that often grow rapidly.
The clinical diagnosis of RIS in the head and neck can 
be difficult because of induration and fibrosis within the 
irradiated field; this was also part of the reasons for the late 
diagnosis of most RIS. Prompt investigation based on the 
patient’s symptoms, especially the appearance of or a change 
in the character of, pain or a mass in the irradiated area sev-
eral years after RT, could lead to an early diagnosis. Hetero-
geneous soft tissue masses with large size, extensive local 
invasion and (or) bony destruction in the irradiated fields on 
imaging examinations are the main clues to the diagnosis of 
RIS; if possible, histopathological results are needed.
Most RIS in the series were advanced at diagnosis, lead-
ing to a poor prognosis. Apart from eight patients hav-
ing missing follow-up, 88.5 % of patients had recurrent or 
uncontrolled lesions exactly at the original site of RIS, which 
was consistent with data from other studies [13, 16–18]. It is 
generally accepted that complete surgical resection provides 
the only chance of cure [13, 16–19], but most sarcomas were 
not resectable because of their deep-seated location, close to 
vital structures, and advanced stage at the time of diagnosis. 
Imaging may potentially improve prognosis by allowing the 
detection of RIS at an earlier stage and by providing pre-
operative mapping of the complete extent of the sarcomas. 
Besides, sarcomas did not respond well to RT or chemother-
apy [3, 4, 17]; RIS receiving RT or (and) chemotherapy only 
in this study showed worse results of persistent lesions.
Fig. 5  Radiation-induced fibrosarcoma 10 years after radiotherapy of 
a 50-year-old man. Axial contrast-enhanced CT image showed a large 
heterogeneously marked enhanced tumor with wide invasion into the 
muscles in the right lower neck (arrows)
Fig. 6  Radiation-induced undifferentiated pleomorphic sarcoma 
13 years after radiotherapy of a 40-year-old man. Axial contrast-
enhanced CT image (a) showed a large heterogeneously marked 
enhanced tumor in the nasal cavity and left maxillary sinus (arrows); 
axial CT on bony window (b) of bone destruction
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A few limitations are identified in this study. Firstly, the 
estimated prevalence did not reflect the true number of RIS in 
post-RT NPC patients. This is because some patients undergo 
CT/MRI examinations and treatments in other institutions. 
That is to say, unfortunately, we had reported insufficient data 
to a certain extent. Secondly, it is acknowledged that some 
of the carcinomas may have been the second primary tumors 
rather than RIS, although our arguments for believing they 
are related to radiation have been discussed. Thirdly, patients 
in this study received conventional radiotherapy rather than 
IMRT. It is possible that IMRT with the delivery of a higher 
integral dose and also the additional effect of chemotherapy 
(neoadjuvant and/or concurrent chemotherapy) in some 
patients may also impact on the risk of developing RIS. Fur-
ther studies are needed to explicitly state the issue.
Conclusion
The current retrospective study confirmed the wide variety of 
locations and histological subtypes, latency as well as poor 
prognosis of RIS in the head and neck after RT for NPC. The 
imaging findings are not diagnosis specific, but all RISs were 
heterogeneous and well-enhanced mass. Radiologists should 
carefully scrutinize each scan, especially the irradiated field, 
to avoid missing any potential RIS lesions. For patients with 
NPC who received RT, when any clinical features suggest 
deterioration in the irradiated area, a prompt investigation, 
including an imaging examination when necessary, may help 
to provide an earlier diagnosis of RIS.
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Table 4  Subgroup comparison of radiological findings between osteosarcoma and fibrosarcoma
‡ The most common sites











Yes No Ill Well Yes No Yes No Heterogeneous Homogeneous
Osteosarcoma 24 Maxillary sinus and mandibular ramus 20 4 21 3 23 1 10 14 24
Fibrosarcoma 22 Neck, maxillary sinus and mandibular ramus 14 8 16 6 9 13 22
Table 5  Treatment and outcomes of radiation-induced sarcomas (n = 69)
Outcomes Treatment
Surgery Chemotherapy Radiotherapy (RT) Surgery + chemo-
therapy
Surgery + RT Chemoradiation No treatment
No. of cases 42 10 2 1 (preopera-
tive chemo-








31 8 1 4 1 1
No recurrence 6
Missing follow-up 5 2 1
Latency of recur-
rence (months)
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